Hydroxyl radical generation following ischaemia-reperfusion in cell-free perfused rat kidney. 1995

M Kadkhodaee, and Z H Endre, and R A Towner, and M Cross
Department of Medicine, University of Queensland, Brisbane, Australia.

The difficulty in direct detection of oxygen-derived free radicals (OFR) in the intact kidney has left uncertain the role of OFR in renal hypoperfusion injury. Salicylate hydroxylation was used as a sensitive method of estimating the extent of production of highly reactive hydroxyl radicals in renal ischaemia-reperfusion injury in the intact rat kidney perfused with recirculating cell-free medium. The reaction products were detected and quantified by HPLC with electrochemical detection. Hydroxyl radicals were detected as 2,5-dihydroxybenzoic acid (2,5-DHBA). Ischaemia for 15 min followed by reperfusion for 15 min caused more than a twofold increase in 2,5-DHBA concentration (to 2279 +/- 225 pg/g tissue weight) compared to controls (933 +/- 103, P < 0.001). Addition of 15 mM dimethylthiourea (DMTU) before induction of ischaemia prevented this increase. Induction of hypoxia for 15 min with continued perfusion (as a model of low-flow ischaemia) had no significant effect on hydroxyl radical formation. We conclude that significant quantities of hydroxyl radicals form in the absence of circulating leucocytes during reperfusion following ischaemia, but not during hypoxia in the perfused rat kidney.

UI MeSH Term Description Entries
D007511 Ischemia A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION. Ischemias
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D005841 Gentisates Salts and esters of gentisic acid. 2,5-Dihydroxybenzoic Acids,2,5 Dihydroxybenzoic Acids,Acids, 2,5-Dihydroxybenzoic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000860 Hypoxia Sub-optimal OXYGEN levels in the ambient air of living organisms. Anoxia,Oxygen Deficiency,Anoxemia,Deficiency, Oxygen,Hypoxemia,Deficiencies, Oxygen,Oxygen Deficiencies
D012459 Salicylates The salts or esters of salicylic acids, or salicylate esters of an organic acid. Some of these have analgesic, antipyretic, and anti-inflammatory activities by inhibiting prostaglandin synthesis. Salicylate,Salicylic Acids,Acids, Salicylic
D015424 Reperfusion Restoration of blood supply to tissue which is ischemic due to decrease in normal blood supply. The decrease may result from any source including atherosclerotic obstruction, narrowing of the artery, or surgical clamping. It is primarily a procedure for treating infarction or other ischemia, by enabling viable ischemic tissue to recover, thus limiting further necrosis. However, it is thought that reperfusion can itself further damage the ischemic tissue, causing REPERFUSION INJURY. Reperfusions
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats

Related Publications

M Kadkhodaee, and Z H Endre, and R A Towner, and M Cross
September 1993, Experimental eye research,
M Kadkhodaee, and Z H Endre, and R A Towner, and M Cross
December 1994, Cardiovascular research,
M Kadkhodaee, and Z H Endre, and R A Towner, and M Cross
January 1990, Free radical biology & medicine,
M Kadkhodaee, and Z H Endre, and R A Towner, and M Cross
August 1997, The Journal of pharmacy and pharmacology,
M Kadkhodaee, and Z H Endre, and R A Towner, and M Cross
August 1998, European journal of gastroenterology & hepatology,
M Kadkhodaee, and Z H Endre, and R A Towner, and M Cross
February 1994, Clinical and experimental pharmacology & physiology,
M Kadkhodaee, and Z H Endre, and R A Towner, and M Cross
March 1987, Proceedings of the National Academy of Sciences of the United States of America,
M Kadkhodaee, and Z H Endre, and R A Towner, and M Cross
March 2023, Physiological reports,
M Kadkhodaee, and Z H Endre, and R A Towner, and M Cross
June 1989, The Journal of biological chemistry,
M Kadkhodaee, and Z H Endre, and R A Towner, and M Cross
June 1994, Annals of the New York Academy of Sciences,
Copied contents to your clipboard!